Gastric xanthelasma may be a warning sign for the presence of early gastric cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 5, 2014, Pages 951-956

  Sekikawa, Akira ^a   Fukui, Hirokazu ^b   Maruo, Takanori ^a   Tsumura, Takehiko ^a   Kanesaka, Takashi ^a   Okabe, Yoshihiro ^a   Osaki, Yukio ^a  

^a OSAKA RED CROSS HOSPITAL   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Age; Atrophic gastritis; Gastric cancer; Gastric xanthelasma

Indexed keywords

AGE; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER PATIENT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GASTRIC XANTHELASMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; UPPER GASTROINTESTINAL TRACT; XANTHOMA; COMPLICATION; GASTRITIS, ATROPHIC; GASTROSCOPY; MIDDLE AGED; PATHOLOGY; PREVALENCE; STOMACH DISEASES; STOMACH NEOPLASMS; XANTHOMATOSIS;

AGED; FEMALE; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STOMACH DISEASES; STOMACH NEOPLASMS; XANTHOMATOSIS;

EID: 84898885516     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12512     Document Type: Article

References (30)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006; 24: 2137-2150.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127: 2893-2917.
3. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J. Clin. Oncol. 2004; 22: 2395-2403.
4. Sekikawa A, Fukui H, Zhang X etal. REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer. Br. J. Cancer 2013; 108: 395-401.
5. Parsonnet J, Friedman GD, Vandersteen DP etal. Helicobacter pylori infection and risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-1131.
6. Nomura A, Stemmmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and risk of gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991; 325: 1132-1136.
7. Uemura N, Okamoto S, Yamamoto S etal. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-789.
8. De Vries AC, van Grieken NC, Looman CW etal. Gastric cancer risk in patients with premalignancy lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952.
9. Yamaji Y, Mitsushima T, Ikuma H etal. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis 5732 Japanese subjects. Gut 2001; 49: 335-340.
10. Kaiserling E, Heine H, Itabe H, Takano T, Remmele W. Lipid islands in human gastric mucosa: morphological and immunohistochemical findings. Gastroenterology 1996; 110: 369-374.
11. Petov S, Churtchev J, Mitova R, Boyanova L, Tarassov M. Xanthoma of the stomach-some morphometrical peculiarities and scanning electron microscopy. Hepatogastroenterology 1999; 46: 1220-1222.
12. Chen YS, Lin JB, Dai KS etal. Gastric xanthelasma. Chin. Med. J. 1989; 102: 639-643.
13. Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun N. Xanthelasmas of the upper gastrointestinal tract. J. Gastroenterol. 2004; 39: 215-219.
14. Yi SY. Dislipidmia and H Pylori in gastric xanthomatosis. World J. Gastroenterol. 2007; 13: 4598-4601.
15. Isomoto H, Mizuta Y, Inoue K etal. A close relationship between Helicobacter pylori infection and gastric xanthoma. Scand. J. Gastroenterol. 1999; 34: 346-352.
16. Kimura K, Takemoto T. An endoscopic recognization of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1: 87-97.
17. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentration. Gut 1999; 44: 693-697.
18. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
19. Kikuchi S, Wada O, Nakajima T etal. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1995; 75: 2789-2793.
20. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res. 1995; 15: 603-606.
21. Webb PM, Yu MC, Forman D etal. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int. J. Cancer 1996; 67: 603-607.
22. Naylor GM, Gotoda T, Dixon M etal. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55: 1545-1552.
23. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5: 5-11.
24. Shipponen P, Kekki M, Siurala M. Increase risk of gastric cancer in males affects the intestinal type of cancer and is independent of age, location of the tumour and atrophic gastritis. Br. J. Cancer 1988; 57: 332-336.
25. You WC, Blot WJ, Li JY etal. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 1993; 53: 1317-1321.
26. Tatsuta M, Iishi H, Nakaizumi A etal. Fundal atrophic gastritis as a risk factor for gastric cancer. Int. J. Cancer 1993; 53: 70-74.
27. Watabe H, Mitsushima T, Yamaji Y etal. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-768.
28. Farinati F, Cardin R, Dagan P etal. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998; 42: 351-356.
29. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 2001; 48: 743-751.
30. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362.